Discover

ICU
SeaStar Medical Holding Corporation
2.24
9 x 2.15
1 x 2.49
bid
ask
-
0.07
3.03%
5 @ 06:09 PM
2.22 -0.02 (0.89%)
Ytd-6.67%
1y-59.64%
2.14
day range
2.30
2.07
52 week range
6.00
Open2.30Prev Close2.31Low2.14High2.30Mkt Cap11.78M
Vol81.71KAvg Vol123.85KEPS-2.97P/EN/AForward P/E-0.77
Beta-1.06Short Ratio4.33Inst. Own4.94%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1550-d Avg3.22200-d Avg3.331yr Est7.00

ICU News

benzinga.com
SeaStar Medical Reports 65.1% Survival Rate At Day 90 In Its QUELIMMUNE SAVE Registry Analysis Prese

SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on t

SeaStar Medical Reports Statistically Significant Survival Findings from Post-Approval QUELIMMUNE® SAVE Registry Analysis in Pediatric Sepsis-Associated AKI
globenewswire.com
SeaStar Medical Reports Statistically Significant Survival Findings from Post-Approval QUELIMMUNE® S

New late-breaking data presented today at ASN Kidney Week 2026 QUELIMMUNE (SCD-PED) treatment group

ICU Medical Announces Time of Third Quarter 2026 Earnings Conference Call
globenewswire.com
ICU Medical Announces Time of Third Quarter 2026 Earnings Conference Call

SAN CLEMENTE, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader i

SeaStar Medical Chief Medical Officer Kevin Chung, MD, Named 2026 Recipient of the Combat Nephrology Award
globenewswire.com
SeaStar Medical Chief Medical Officer Kevin Chung, MD, Named 2026 Recipient of the Combat Nephrology

Award recognizes Dr. Chung's extraordinary career as an internationally known expert in burn critica

benzinga.com
SeaStar Medical Receives FDA's Medical Breakthrough Device Designation For Its Selective Cytophereti

SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on t

FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition
globenewswire.com
FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of

Potentially accelerates development, assessment, and review for approval by FDA Sepsis impacts about

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

Gainers HeartBeam (NASDAQ:BEAT) stock moved upwards by 70.5% to $0.74 during Monday's regular s

SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds
globenewswire.com
SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds

DENVER, Oct. 05, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

Gainers Stablecoin Development (AMEX:SDEV) shares moved upwards by 66.9% to $6.11 during Friday&#39

SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026
globenewswire.com
SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026

DENVER, Oct. 02, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a comme

New ICD-10-PCS Codes are Now Available for the Use of SeaStar Medical's SCD Therapy for Acute Kidney Injury (AKI)
globenewswire.com
New ICD-10-PCS Codes are Now Available for the Use of SeaStar Medical's SCD Therapy for Acute Kidney

New codes streamline hospital billing, enable tracking of clinical outcomes, and expand access to QU

SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026
globenewswire.com
SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Para

Dr. Chung to deliver an oral presentation highlighting QUELIMMUNE ® , an advanced extracorporeal the

SeaStar Medical Congratulates H. David Humes, M.D.
globenewswire.com
SeaStar Medical Congratulates H. David Humes, M.D.

Prestigious honor recognizes Dr. Humes' pioneering work in developing the Selective Cytopheretic Dev

SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference
globenewswire.com
SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference

DENVER, Sept. 10, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a comm

Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah's Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU
globenewswire.com
Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah's Story Featuring Laura Wright-Sexton

Quoin Pharmaceuticals releases a new NETHERTON NOW video featuring Laura Wright-Sexton, MD, who firs

ICU Medical to Participate in Upcoming Investor Conferences
globenewswire.com
ICU Medical to Participate in Upcoming Investor Conferences

SAN CLEMENTE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader i

SeaStar Medical Holding Corporation (ICU) Q2 2026 Earnings Call Transcript
seekingalpha.com
SeaStar Medical Holding Corporation (ICU) Q2 2026 Earnings Call Transcript

SeaStar Medical Holding Corporation (ICU) Q2 2026 Earnings Call Transcript

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com
SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Added 3 top-rated children's hospitals to QUELIMMUNE ® pediatric acute kidney injury (AKI) customer

ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings
benzinga.com
ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings

ICU Medical Inc (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.

ICU Medical Q2 Earnings Call Highlights
marketbeat.com
ICU Medical Q2 Earnings Call Highlights

ICU Medical NASDAQ: ICUI reported second-quarter revenue of $548 million, up 6% organically and 1% o

ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance
globenewswire.com
ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance

SAN CLEMENTE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026
globenewswire.com
SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a comme

ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
globenewswire.com
ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call

SAN CLEMENTE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader i

SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)
globenewswire.com
SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (A

Sponsors educational summit of leading pediatric AKI health care experts Announces best practices we

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers Can Fite Biopharma (AMEX:CANF) shares rose 43.8% to $4.27 during Wednesday's regular se

benzinga.com
SeaStar Medical's Selective Cytopheretic Device Receives Dedicated International Classification of D

SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on t

benzinga.com
Maxim Group Maintains Buy on SeaStar Medical Holding, Raises Price Target to $8

Maxim Group analyst Anthony Vendetti maintains SeaStar Medical Holding (NASDAQ:ICU) with a Buy an

Full Transcript: SeaStar Medical Holding Q1 2026 Earnings Call
benzinga.com
Full Transcript: SeaStar Medical Holding Q1 2026 Earnings Call

benzinga.com
SeaStar Medical Holding Q1 EPS $(0.90) Misses $(0.82) Estimate, Sales $495.000K Beat $437.500K Estim

SeaStar Medical Holding (NASDAQ:ICU) reported quarterly losses of $(0.90) per share which missed the

Earnings Scheduled For May 13, 2026
benzinga.com
Earnings Scheduled For May 13, 2026

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga.com
SeaStar Medical Holding Q4 EPS $(0.80) Beats $(1.01) Estimate, Sales $420.000K Beat $372.500K Estima

SeaStar Medical Holding (NASDAQ:ICU) reported quarterly losses of $(0.80) per share which beat the a

Earnings Scheduled For March 25, 2026
benzinga.com
Earnings Scheduled For March 25, 2026

benzinga.com
SeaStar Medical Publishes Data On Early Post-Approval Clinical Experience From Use Of QUELIMMUNE Dev

SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company, announced t

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

SeaStar Medical, Jet.AI And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
benzinga.com
SeaStar Medical, Jet.AI And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Why Multi Ways Holdings Shares Are Trading Higher By Around 60%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Multi Ways Holdings Shares Are Trading Higher By Around 60%; Here Are 20 Stocks Moving Premarket

benzinga.com
SeaStar Medical Holding Announces 1-For-10 Reverse Stock Split, Effective January 5, 2026

SeaStar Medical Holding Corporation (NASDAQ: ICU), a commercial-stage healthcare company focused on

What's Going On With Shares Of SeaStar Medical Today?
benzinga.com
What's Going On With Shares Of SeaStar Medical Today?

Shares of SeaStar Medical Holding Corporation (NASDAQ: ICU) are trading lower Friday after the compa

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Why Oracle Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Oracle Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
SeaStar Medical Appoints Michael Messinger CFO

SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

benzinga.com
SeaStar Medical Holding Q3 EPS $(0.13) Beats $(0.15) Estimate, Sales $183.000K Miss $250.000K Estima

SeaStar Medical Holding (NASDAQ:ICU) reported quarterly losses of $(0.13) per share which beat the a

Earnings Scheduled For November 13, 2025
benzinga.com
Earnings Scheduled For November 13, 2025

A Glimpse of SeaStar Medical Holding's Earnings Potential
benzinga.com
A Glimpse of SeaStar Medical Holding's Earnings Potential